# SIRT1 reduction causes renal and retinal injury in diabetes through endothelin 1 and transforming growth factor β1

**Authors:** Rokhsana Mortuza, Biao Feng, Subrata Chakrabarti

PMC · DOI: 10.1111/jcmm.12557 · 2015-03-06

## TL;DR

Reduced SIRT1 in diabetes leads to kidney and eye damage by increasing ET-1 and TGF-β1, which can be prevented by SIRT1 overexpression.

## Contribution

This study reveals a novel protective role of SIRT1 against diabetes-induced renal and retinal injury via regulation of ET-1 and TGF-β1.

## Key findings

- High glucose increases ET-1, TGF-β1, and collagen Iα(I) in endothelial cells.
- SIRT1 overexpression reduces diabetes-related kidney and retinal damage in mice.
- p300 and histone acetylation mediate the effects of SIRT1 in glucose-induced injury.

## Abstract

In diabetes, hyperglycaemia causes up-regulation of endothelin 1 (ET-1) and transforming growth factor beta 1 (TGF-β1). Previously we showed glucose reduces sirtuin1 (SIRT1), a class III histone deacetylase. Here, we investigated the regulatory role of SIRT1 on ET-1 and TGF-β1 expression. Human microvascular endothelial cells were examined following incubation with 25 mmol/l glucose (HG) and 5 mmol/l glucose (NG) with or without SIRT1 or histone acetylase p300 overexpression or knockdown. mRNA expressions of ET-1, TGF-β1, SIRT1, p300 and collagen 1α(I) were examined. SIRT1 enzyme activity, ET-1 and TGF-β1 protein levels were measured. Histone acetylation and endothelial permeability were further investigated. Similar analyses were performed in the kidneys and retinas of SIRT1 overexpressing transgenic mice with or without streptozotocin induced diabetes. Renal functions were evaluated. In the endothelial cells (ECs), HG caused increased permeability and escalated production of ET-1, TGF-β1, collagen Iα(I). These cells also showed increased p300 expression, histone acetylation and reduced SIRT1 levels. These changes were rectified in the ECs following p300 silencing or by SIRT1 overexpression, whereas SIRT1 knockdown or p300 overexpression in NG mimicked the effects of HG. High ET-1 and TGF-β1 levels were seen in the kidneys and retinas of diabetic mice along with micro-albuminuria and increased fibronectin protein (marker of glucose-induced cell injury) levels. Interestingly, these detrimental changes were blunted in SIRT1 overexpressing transgenic mice with diabetes. This study showed a novel SIRT1 mediated protection against renal and retinal injury in diabetes, regulated through p300, ET-1 and TGF-β1.

## Linked entities

- **Genes:** SIRT1 (sirtuin 1) [NCBI Gene 23411], EDN1 (endothelin 1) [NCBI Gene 1906], TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040], EP300 (EP300 lysine acetyltransferase) [NCBI Gene 2033]
- **Proteins:** SIRT1 (sirtuin 1), EP300 (EP300 lysine acetyltransferase), fn1.S (fibronectin 1 S homeolog)
- **Diseases:** diabetes (MONDO:0005015)

## Full-text entities

- **Genes:** Mir146 (microRNA 146) [NCBI Gene 387164] {aka Mirn146, miR-146a, mmu-mir-146}, Ep300 (E1A binding protein p300) [NCBI Gene 328572] {aka A430090G16, A730011L11, KAT3B, p300, p300 HAT}, Mir195a (microRNA 195a) [NCBI Gene 387190] {aka Mir195, Mirn195, mir-195a, mmu-mir-195, mmu-mir-195a}, nej (nejire) [NCBI Gene 43856] {aka CBP, CBP/p300, CBP_, CG15319, CG15321, Cbp}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, SIRT1 (sirtuin 1) [NCBI Gene 23411] {aka SIR2, SIR2L1, SIR2alpha}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Edn1 (endothelin 1) [NCBI Gene 13614] {aka ET-1, PPET1, preproET}, Smad7 (SMAD family member 7) [NCBI Gene 17131] {aka Madh7}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, Jun (Jun proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 16476] {aka AP-1, Junc, c-jun}, Sirt1 (Sirtuin 1) [NCBI Gene 34708] {aka BEST:LD38188, CG5216, D.mel1, DSir2, Dmel\CG5216, SIR-2}, EP300 (EP300 lysine acetyltransferase) [NCBI Gene 2033] {aka KAT3B, MKHK2, RSTS2, p300}, Alb (albumin) [NCBI Gene 11657] {aka Alb-1, Alb1, BCL001, BCL002, BPL001}, Sirt1 (sirtuin 1) [NCBI Gene 93759] {aka SIR2L1, Sir2, Sir2a, Sir2alpha}, Fn1 (fibronectin 1) [NCBI Gene 14268] {aka E330027I09, Fn, Fn-1}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, InR (Insulin-like receptor) [NCBI Gene 42549] {aka 18402, CG18402, DIHR, DILR, DIR, DIRH}, Mir200b (microRNA 200b) [NCBI Gene 387243] {aka Mirn200b, mir-200b}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, EDN1 (endothelin 1) [NCBI Gene 1906] {aka ARCND3, ET1, HDLCQ7, PPET1, QME}, KAT2B (lysine acetyltransferase 2B) [NCBI Gene 8850] {aka CAF, P/CAF, PCAF}
- **Diseases:** renal and retinal injury (MESH:D012173), Cancer (MESH:D009369), fibrosis (MESH:D005355), organ damage (MESH:D000092124), vascular damage (MESH:D057772), micro-albuminuria (MESH:D000419), diabetic complication (MESH:D048909), Diabetic (MESH:D003920), endothelial dysfunctions (MESH:D014652), chronic (MESH:D002908), diabetic microangiopathy (MESH:D003925), renal and retinal damages (MESH:D012164), nephropathy (MESH:D007674), renal and retinal microangiopathy (MESH:C537580), retinopathy (MESH:D058437), renal mesangial expansion (MESH:C537346), inflammatory cytokines (MESH:D000080424), diabetic nephropathy (MESH:D003928),  (MESH:D003921)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Adenoviridae (family) [taxon 10508]
- **Cell lines:** C57BL/ — Homo sapiens (Human), Burkitt lymphoma, Cancer cell line (CVCL_C152), HMECs — Homo sapiens (Human), Transformed cell line (CVCL_0307), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), HEK293A — Homo sapiens (Human), Transformed cell line (CVCL_0045)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4549036/full.md

---
Source: https://tomesphere.com/paper/PMC4549036